Impact Events
MoreDate | Lead Company | Event | Type | Approval Change | Approval Likelihood |
---|---|---|---|---|---|
1/17/25 | Novo Nordisk (NVO) | Wegovy for Obesity | Subscribers Only | Subscribers Only | Subscribers Only |
1/16/25 | Boehringer | BI-425809 for Schizophrenia | Subscribers Only | Subscribers Only | Subscribers Only |
1/15/25 | OS Therapies (OSTX) | OST-HER2 for Osteosarcoma | Subscribers Only | Subscribers Only | Subscribers Only |
1/14/25 | Sling Therapeutics | Linsitinib for Thyroid Eye Disease (TED) | Subscribers Only | Subscribers Only | Subscribers Only |
1/14/25 | Immuron (IMC) | Travelan for Gastroenteritis | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
MoreExpected Date Range | Lead Company | Drug | Expected Catalyst |
---|---|---|---|
09/12/2024 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
10/16/2024 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
10/30/2024 | Subscribers Only | Subscribers Only | Progress Update - Development Review |
11/15/2024 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
11/19/2024 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |